In the UK, deep vein thrombosis (DVT) and pulmonary embolism (PE) are treated with anticoagulant medications, commonly known as blood thinners. According to NICE guidelines, the primary treatments are Direct Oral Anticoagulants (DOACs), with apixaban and rivaroxaban being the most frequently prescribed first-line options. These medications do not actually thin the blood but instead interrupt the chemical process that allows clots to form, preventing existing clots from growing and significantly reducing the risk of new ones developing.
What We will cover in this Article
- The role of Direct Oral Anticoagulants (DOACs) as first-line treatment
- Differences between apixaban, rivaroxaban, edoxaban, and dabigatran
- When injectable anticoagulants (heparin) are used
- The use of warfarin and the requirement for INR monitoring
- Potential side effects and bleeding risks associated with blood thinners
- How doctors choose the right medication for your specific needs
- Emergency signs to watch for while on anticoagulant therapy
First-line treatments: Direct Oral Anticoagulants (DOACs)
DOACs have become the standard treatment for most adults with DVT or PE in the NHS. They are preferred because they offer a predictable effect and do not require the regular blood tests that were mandatory with older medications. Apixaban and rivaroxaban are unique because they can be started immediately as tablets, whereas other DOACs like edoxaban or dabigatran require a short initial period of blood-thinning injections.
The dosing for these medications usually involves a higher loading dose for the first week or three weeks to quickly stabilise the clot, followed by a lower maintenance dose. For example, apixaban is typically taken twice daily, while rivaroxaban may be transitioned to a once-daily dose after the initial three-week period. Because these drugs are cleared by the kidneys, your doctor will perform baseline blood tests to ensure your renal function is healthy enough to process the medication safely.
Injectable anticoagulants: Heparin and LMWH
Low molecular weight heparin (LMWH), such as tinzaparin or enoxaparin, is an injectable blood thinner often used in the acute phase of treatment. These injections are usually administered into the fatty tissue of the abdomen. While DOACs have replaced injections for many, LMWH remains the treatment of choice for specific groups, including pregnant women, as these medications do not cross the placenta to affect the baby.
Injections are also used:
- As a bridge therapy: While waiting for warfarin to become effective.
- For cancer-associated thrombosis: Where they may be more effective than tablets.
- In hospital settings: For patients who are too unwell to take oral medication or those with severe kidney failure.
- Pre-treatment: For at least five days before starting edoxaban or dabigatran.
Traditional treatment: Warfarin
Warfarin is an older type of anticoagulant that has been used for decades. Unlike DOACs, warfarin’s effectiveness is heavily influenced by diet, other medications, and alcohol consumption. Patients on warfarin must have regular blood tests called INR (International Normalised Ratio) tests to measure how long it takes for their blood to clot. The dose is then adjusted to keep the INR within a specific target range, usually between 2.0 and 3.0.
While warfarin is used less frequently today, it remains essential for certain patients. This includes those with mechanical heart valves, specific blood disorders like antiphospholipid syndrome, or those with severe kidney disease where DOACs are not safe. Managing warfarin requires a consistent intake of vitamin K, found in green leafy vegetables, as sudden changes in your diet can cause your INR levels to fluctuate.
Side effects and safety considerations
All blood thinners carry a risk of bleeding because they reduce the body’s ability to form clots. Most side effects are mild, such as bruising more easily or minor nosebleeds. However, clinicians must balance the benefit of preventing a life-threatening pulmonary embolism against the risk of a serious bleed. You will typically be given an anticoagulant alert card to carry with you in case of an emergency.
Common side effects include:
- Increased bruising: Even from minor bumps.
- Prolonged bleeding from small cuts: Often requiring firm pressure for longer than usual.
- Heavier periods: For those who menstruate.
- Occasional headaches or dizziness.
- Indigestion or nausea: Particularly with certain tablet types.
Choosing the right anticoagulant
The choice of blood thinner is a personalised decision made between you and your clinical team. Factors such as your age, weight, kidney function, and other health conditions like cancer or heart valve issues play a significant role. For many, the convenience of a once or twice daily tablet like a DOAC, without the need for regular clinic visits, makes it the preferred option.
Doctors also consider:
- Ease of use: Whether you prefer a once-daily or twice-daily tablet.
- Reversibility: Whether an antidote is available in the event of a major bleed.
- Dietary habits: Whether you can maintain a consistent diet required for warfarin.
- Existing medications: Ensuring there are no dangerous drug-to-drug interactions.
Conclusion
Blood thinners are a life-saving treatment for DVT and PE, with modern DOACs providing a safe and convenient option for most patients in the UK. Whether you are prescribed a tablet or an injection, the goal remains the same: to stop the clot from causing harm while your body heals. Understanding your medication and taking it consistently is the most important step in your recovery.
If you experience severe, sudden, or worsening symptoms, call 999 immediately.
‘Do blood thinners actually thin the blood?’
No, they do not change the thickness or viscosity of your blood; they simply slow down the chemical reaction that causes it to clot.
‘Can I take aspirin with my blood thinner?’
You should generally avoid aspirin and other NSAIDs like ibuprofen while on anticoagulants unless specifically told otherwise by your doctor, as they significantly increase the risk of bleeding.
‘What happens if I cut myself?’
Most minor cuts will stop with firm, continuous pressure for 5 to 10 minutes. If bleeding does not stop after 10 minutes, you should seek medical advice.
‘Are there any foods I must avoid on DOACs?’
Unlike warfarin, DOACs (like apixaban) do not have major dietary restrictions, although it is always wise to maintain a balanced diet and moderate alcohol intake.
‘How long will I be on these medications?’
Most people take them for 3 to 6 months for a first clot, though some may need them lifelong if the risk of recurrence is high.
‘Can I travel while on blood thinners?’
Yes, but you should stay hydrated and move around frequently. If you are on warfarin, you may need to arrange an INR test if you are away for a long time.
‘Is it safe to have surgery while on these drugs?’
You will usually need to stop your blood thinners for a short period before any planned surgery or dental work. Your surgeon will provide a specific plan for this.
Authority Snapshot
This article outlines the pharmacological management of venous thromboembolism as practiced within the UK. It follows the therapeutic guidelines provided by NICE and the British National Formulary (BNF). The information is intended to help patients understand the different classes of anticoagulants and the importance of medication adherence for safety. Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.
